Works by Jaetaek Kim


Results: 25
    1
    2
    3
    4
    5
    6

    A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naïve patients with type 2 diabetes.

    Published in:
    Endocrine Journal, 2015, v. 62, n. 5, p. 449, doi. 10.1507/endocrj.ej14-0544
    By:
    • Hae Kyung Yang;
    • Kyung Wan Min;
    • Sung Woo Park;
    • Choon Hee Chung;
    • Kyong Soo Park;
    • Sung Hee Choi;
    • Ki-Ho Song;
    • Doo-Man Kim;
    • Moon-Kyu Lee;
    • Yeon-Ah Sung;
    • Sei Hyun Baik;
    • In Joo Kim;
    • Bong-Soo Cha;
    • Jeong Hyun Park;
    • Yu Bae Ahn;
    • In-Kyu Lee;
    • Soon Jib Yoo;
    • Jaetaek Kim;
    • Ie Byung Park;
    • Tae Sun Park
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    A Case of Diabetic Mastopathy.

    Published in:
    Endocrinology & Metabolism, 2012, v. 27, n. 3, p. 244, doi. 10.3803/enm.2012.27.3.244
    By:
    • Seok Hong Lee;
    • Bo Min Kim;
    • Jae Woong Kim;
    • Moon-Ki Hong;
    • Seonghyeop Hyeon;
    • Mi Yi Kim;
    • Jaetaek Kim;
    • Jihyun Ahn
    Publication type:
    Article
    17
    18
    19
    20

    Thyrocyte‐specific deletion of insulin and IGF‐1 receptors induces papillary thyroid carcinoma‐like lesions through EGFR pathway activation.

    Published in:
    International Journal of Cancer, 2018, v. 143, n. 10, p. 2458, doi. 10.1002/ijc.31779
    By:
    • Ock, Sangmi;
    • Ahn, Jihyun;
    • Lee, Seok Hong;
    • Kim, Hyun Min;
    • Kang, Hyun;
    • Kim, Young‐Kook;
    • Kook, Hyun;
    • Park, Woo Jin;
    • Kim, Shin;
    • Kimura, Shioko;
    • Jung, Chan Kwon;
    • Shong, Minho;
    • Holzenberger, Martin;
    • Abel, E. Dale;
    • Lee, Tae Jin;
    • Cho, Bo Youn;
    • Kim, Ho‐Shik;
    • Kim, Jaetaek
    Publication type:
    Article
    21
    22
    23

    Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, placebo-controlled study ( TROICA study)

    Published in:
    Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 635, doi. 10.1111/dom.12866
    By:
    • Ahn, Chang Ho;
    • Han, Kyung Ah;
    • Yu, Jae Myung;
    • Nam, Joo Young;
    • Ahn, Kyu Jeung;
    • Oh, Tae Keun;
    • Lee, Hyoung Woo;
    • Lee, Dae Ho;
    • Kim, Jaetaek;
    • Chung, Choon Hee;
    • Park, Tae Sun;
    • Kim, Byung Joon;
    • Park, Seok Won;
    • Park, Hyeong Kyu;
    • Lee, Kwang Jae;
    • Kim, Sang‐Wook;
    • Park, Jeong Hyun;
    • Ko, Kwan Pyo;
    • Kim, Chong Hwa;
    • Lee, Hyunjin
    Publication type:
    Article
    24
    25